First real-life experiences with 2 mg bulevirtide for the treatment of hepatitis delta-data from a tertiary reference centre in Germany

被引：0
|
作者：
Zoellner, Caroline [1 ,2 ]
Lutz, Katrin [1 ,2 ]
Demir, Muenevver [1 ,2 ]
Tacke, Frank [1 ,2 ]
机构：
[1] Charite Univ Med Berlin, Dept Gastroenterol & Hepatol, Campus Virchow Klinikum, Berlin, Germany
[2] Charite Univ Med Berlin, Dept Gastroenterol & Hepatol, Charite Campus Mitte, Berlin, Germany
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-1419
引用
收藏
页码：S745 / S746
页数：2
相关论文
共 50 条
  • [21] First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real-life' settings: from clinical trials to clinical practice
    Pol, S.
    Lampertico, P.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (06) : 377 - 386
  • [22] Direct-acting antiviral agents in the treatment of chronic Hepatitis C - "Real-life" experience from an academic centre and two specialized clinical practices
    Gross, Manuel Jonathan
    Haerter, Georg
    Backhus, Johanna
    Zizer, Eugen
    Seufferlein, Thomas
    Ludwig, Leopold
    Dikopoulos, Nektarios
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (04): : 351 - 360
  • [23] Effectiveness and potential drug interactions in antiviral therapy for the treatment of chronic hepatitis C: real-life data from a specialized center in southern Brazil
    Schwambach, Karin Hepp
    Blatt, Carine Raquel
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 57
  • [24] Treatment persistence in bio-naive patients with long-standing Crohn's disease treated with first-line biologics: real-life data from a Croatian tertiary center
    Biscanin, A.
    Tomasic, V.
    Babic, F.
    Dorosulic, Z.
    Kralj, D.
    Cacic, P.
    Ogresta, D.
    Hrabar, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I470 - I471
  • [25] Treatment persistence in bio-naive patients with long-standing Crohn's disease treated with first-line biologics: real-life data from a Croatian tertiary center
    Biscanin, A.
    Tomasic, V.
    Babic, F.
    Dorosulic, Z.
    Kralj, D.
    Cacic, P.
    Ogresta, D.
    Hrabar, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I470 - I471
  • [26] Effectiveness of MP-AzeFlu* for the treatment of allergic rhinitis in real-life: meta-analysis of data from Germany, Sweden, Norway, Denmark and Romania
    Klimek, L.
    Stjarne, P.
    Dollner, R.
    Haahr, P.
    Agache, I
    Bachert, C.
    ALLERGY, 2016, 71 : 209 - 210
  • [27] The 8-Year Retention Rate of the First TNF-Inhibitor in the Treatment of Spondyloarthropathies: Real-Life Data from Three Local Registries
    Favalli, Ennio Giulio
    Becciolini, Andrea
    Biggioggero, Martina
    Fusaro, Enrico
    Parisi, Simone
    Ariani, Alarico
    Santilli, Daniele
    Marchesoni, Antonio
    Meroni, Pier Luigi
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [28] THE 8-YEAR RETENTION RATE OF THE FIRST TNF-INHIBITOR IN THE TREATMENT OF SPONDYLOARTHROPATHIES: REAL-LIFE DATA FROM A MULTICENTRIC LOCAL REGISTRIES
    Favalli, E. G.
    Selmi, C.
    Becciolini, A.
    Biggioggero, M.
    Ariani, A.
    Santilli, D.
    Fusaro, E.
    Parisi, S.
    Massarotti, M.
    Marchesoni, A.
    Meroni, P. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 810 - 810
  • [29] Outcome of Single Dexamethasone Implant Injection in the Treatment of Persistent Diabetic Macular Edema After Anti-VEGF Treatment: Real-Life Data from a Tertiary Hospital in Jordan
    Al-Latayfeh, Motasem
    Rahman, Mohammad Abdel
    Shatnawi, Raed
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 1285 - 1291
  • [30] Is treatment outcome affected by the need to obtain health care providers' approval first? Anti-VEGF real-life data from a large cohort in Germany at one center without individual applications
    Wilke, Robert G. H.
    Sachs, Helmut G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
12345